Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LMBR1L | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | ISYNA1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | TBC1D9 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | MT1H | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | SCRN1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | MEDAG | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | BCAR3 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | MAFK | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | TXNDC11 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | FAM3B | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |